MedTrace Logo

Russia PREVENT (HIV Prevention Partnership in Russian Alcohol Treatment)

NCT00183118 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2017-07-21

No results posted yet for this study

Summary

The purpose of this study is to test an HIV prevention intervention in a Russian substance abuse treatment facility using a randomized trial study design.

Conditions

  • Alcohol Dependence
  • Drug Dependence

Interventions

BEHAVIORAL

Adapted Enhanced-RESPECT (HIV prevention intervention)

Sponsors & Collaborators

  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    collaborator NIH

  • Boston Medical Center

    lead OTHER

Principal Investigators

  • Jeffrey H. Samet, MD, MA, MPH · Boston Medical Center

  • Evgeny Krupitsky · Leningrad Regional Center of Addictions Institution: Pavlov State Medical University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-10-31
Completion
2005-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00183118 on ClinicalTrials.gov